NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rhenman & Partners Asset Management AB | 1,307,196 | $26,144,000 | 1.82% |
Camber Capital Management LP | 2,000,000 | $40,000,000 | 1.37% |
Birchview Capital, LP | 92,000 | $1,840,000 | 1.09% |
MAVERICK CAPITAL LTD | 5,858,316 | $117,166,000 | 1.08% |
Bellevue Group AG | 3,954,604 | $79,093,000 | 0.84% |
CM Management, LLC | 50,000 | $1,000,000 | 0.74% |
Goodman Financial Corp | 106,238 | $2,125,000 | 0.68% |
Adero Partners, LLC | 51,500 | $1,030,000 | 0.46% |
Duquesne Family Office | 1,000,000 | $20,000,000 | 0.44% |
OSTERWEIS CAPITAL MANAGEMENT INC | 394,929 | $7,899,000 | 0.43% |
RICE HALL JAMES & ASSOCIATES, LLC | 566,082 | $11,322,000 | 0.37% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,340,000 | 0.35% |
Hennion & Walsh Asset Management, Inc. | 264,701 | $5,294,000 | 0.32% |
Virtus ETF Advisers LLC | 35,476 | $710,000 | 0.30% |
DCF Advisers, LLC | 31,300 | $626,000 | 0.27% |
PRIMECAP MANAGEMENT CO/CA/ | 18,165,369 | $363,307,000 | 0.25% |
PDT Partners, LLC | 164,016 | $3,280,000 | 0.24% |
LIBERTY WEALTH MANAGEMENT LLC | 19,000 | $393,000 | 0.19% |
Invesco Ltd. | 35,449,394 | $708,987,000 | 0.19% |
AdvisorNet Financial, Inc | 129,777 | $2,596,000 | 0.18% |
External links
This page lists NEKTAR THERAPEUTICS's shareholders in Q1 2021. To view NEKTAR THERAPEUTICS's shareholder history, click here.